Stock Screener
Stock Research
Top Dividend Stocks
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy

Regeneron Pharmaceuticals Revenue 2006-2018 | REGN

Current and historical revenue for Regeneron Pharmaceuticals (REGN) from 2006 to 2018. The sum of all revenue fields included for a company's operating activities. The current revenue for Regeneron Pharmaceuticals as of March 31, 2018 is .
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.002B $5.872B
Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates for the potential treatment of obesity, rheumatoid arthritis, cancer, and asthma and has preclinical programs in other diseases and disorders.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $126.048B 14.77
Gilead Sciences (GILD) United States $100.601B 10.04
Biogen (BIIB) United States $75.691B 15.83
Celgene (CELG) United States $61.683B 12.26
Illumina (ILMN) United States $45.739B 64.55
Vertex Pharmaceuticals (VRTX) United States $45.207B 147.83
Alexion Pharmaceuticals (ALXN) United States $30.073B 25.03
BioMarin Pharmaceutical (BMRN) United States $18.007B 0.00
Incyte (INCY) United States $14.668B 0.00
Seattle Genetics (SGEN) United States $11.117B 0.00
Alnylam Pharmaceuticals (ALNY) United States $10.648B 0.00
BeiGene (BGNE) Cayman Islands $9.099B 0.00
Bluebird Bio (BLUE) United States $9.039B 0.00
Sarepta Therapeutics (SRPT) United States $8.736B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.516B 68.69
QIAGEN (QGEN) Netherlands $8.426B 28.18
Exact Sciences (EXAS) United States $8.243B 0.00
Alkermes (ALKS) Ireland $6.983B 0.00
Exelixis (EXEL) United States $6.320B 25.65
Bio-Techne Corp (TECH) United States $5.877B 40.31
Integra LifeSciences Holdings (IART) United States $5.532B 29.69
Galapagos (GLPG) Belgium $5.494B 0.00
Ligand Pharmaceuticals (LGND) United States $4.939B 66.25
MorphoSys AG Unsponsored ADR (MOR) Germany $4.451B 0.00
Immunomedics (IMMU) United States $4.374B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.126B 0.00
Array BioPharma (ARRY) United States $3.577B 0.00
China Biologic Products (CBPO) China $3.395B 22.42
ARGENX SE-ADR (ARGX) Netherlands $3.095B 0.00
Myriad Genetics (MYGN) United States $3.056B 37.04
Spark Therapeutics (ONCE) United States $3.038B 0.00
Amicus Therapeutics (FOLD) United States $3.016B 0.00
Medicines (MDCO) United States $2.930B 0.00
Horizon Pharma Public (HZNP) Ireland $2.882B 17.64
Ascendis Pharma (ASND) Denmark $2.873B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.775B 0.00
CRISPR THERAPTC (CRSP) Switzerland $2.753B 0.00
Blueprint Medicines (BPMC) United States $2.731B 0.00
Emergent Biosolutions (EBS) United States $2.703B 34.56
Akcea Therapeutics (AKCA) United States $2.630B 0.00
Halozyme Therapeutics (HALO) United States $2.612B 40.31
Clovis Oncology (CLVS) United States $2.516B 0.00
REGENXBIO (RGNX) United States $2.446B 56.74
Momenta Pharmaceuticals (MNTA) United States $2.355B 0.00
Arena Pharmaceuticals (ARNA) United States $2.157B 0.00
Global Blood Therapeutics (GBT) United States $2.143B 0.00
Acceleron Pharma (XLRN) United States $2.132B 0.00
Repligen (RGEN) United States $2.132B 67.76
ACADIA Pharmaceuticals (ACAD) United States $2.102B 0.00
MyoKardia (MYOK) United States $2.043B 0.00
Genomic Health (GHDX) United States $2.029B 358.38
Puma Biotechnology (PBYI) United States $1.966B 0.00
Insmed (INSM) United States $1.914B 0.00
Cambrex (CBM) United States $1.847B 16.98
AnaptysBio (ANAB) United States $1.798B 0.00
Atara Biotherapeutics (ATRA) United States $1.723B 0.00
Editas Medicine (EDIT) United States $1.714B 0.00
Aimmune Therapeutics (AIMT) United States $1.693B 0.00
Mirati Therapeutics (MRTX) United States $1.599B 0.00
G1 THERAPEUTICS (GTHX) United States $1.560B 0.00
IMMURON LTD (IMRN) Australia $1.549B 0.00
Sangamo Therapeutics (SGMO) United States $1.533B 0.00
Solid Biosciences (SLDB) United States $1.529B 0.00
Audentes Therapeutics (BOLD) United States $1.522B 0.00
Innoviva (INVA) United States $1.445B 10.59
BIOHAVEN PHARM (BHVN) United States $1.434B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.392B 0.00
Intellia Therapeutics (NTLA) United States $1.363B 0.00
Lexicon Pharmaceuticals (LXRX) United States $1.358B 0.00
Acorda Therapeutics (ACOR) United States $1.353B 0.00
Lion Biotechnologies (IOVA) United States $1.336B 0.00
Myovant Sciences (MYOV) United Kingdom $1.292B 0.00
Denali Therapeutics (DNLI) United States $1.271B 0.00
UniQure (QURE) Netherlands $1.264B 0.00
Cellectis (CLLS) France $1.250B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.221B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.219B 0.00
Reata Pharmaceuticals (RETA) United States $1.214B 0.00
Retrophin (RTRX) United States $1.212B 0.00
Athenex (ATNX) United States $1.197B 0.00
WAVE Life Sciences (WVE) Singapore $1.144B 0.00
NeoGenomics (NEO) United States $1.138B 235.33
Intra-Cellular Therapies (ITCI) United States $1.138B 0.00
Coherus BioSciences (CHRS) United States $1.138B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.084B 0.00
Revance Therapeutics (RVNC) United States $1.082B 0.00
Apellis Pharmaceuticals (APLS) United States $1.023B 0.00
DBV Technologies (DBVT) France $0.986B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.983B 0.00
Dynavax Technologies (DVAX) United States $0.981B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.977B 0.00
CytomX Therapeutics (CTMX) United States $0.951B 0.00
AC Immune SA (ACIU) Switzerland $0.934B 0.00
Epizyme (EPZM) United States $0.931B 0.00
AVROBIO (AVRO) United States $0.869B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.867B 0.00
ANI Pharmaceuticals (ANIP) United States $0.832B 17.03
Amarin (AMRN) Ireland $0.818B 0.00
Heska (HSKA) United States $0.804B 61.58
Inotek Pharmaceuticals (RCKT) United States $0.789B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.768B 0.00
Eidos Therapeutics (EIDX) United States $0.762B 0.00
InflaRx (IFRX) Germany $0.758B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.750B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.735B 0.00
Sorrento Therapeutics (SRNE) United States $0.707B 0.00
Abeona Therapeutics (ABEO) United States $0.679B 0.00
Viking Therapeutics (VKTX) United States $0.662B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.662B 0.00
Kura Oncology (KURA) United States $0.660B 0.00
Aptinyx (APTX) United States $0.658B 0.00
UROGEN PHARMA (URGN) Israel $0.651B 0.00
Arbutus Biopharma (ABUS) Canada $0.637B 0.00
Mesoblast (MESO) Australia $0.623B 0.00
Cara Therapeutics (CARA) United States $0.623B 0.00
UNITY Biotechnology (UBX) $0.623B 0.00
ObsEva SA (OBSV) Switzerland $0.606B 0.00
Tigenix (TIG) Belgium $0.605B 0.00
Five Prime Therapeutics (FPRX) United States $0.598B 0.00
BeyondSpring (BYSI) United States $0.596B 0.00
Geron (GERN) United States $0.594B 0.00
Prothena (PRTA) Ireland $0.591B 0.00
Fate Therapeutics (FATE) United States $0.572B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.555B 0.00
Novavax (NVAX) United States $0.546B 0.00
Aduro Biotech (ADRO) United States $0.543B 0.00
Senesco Technologies (ELOX) United States $0.543B 0.00
Merus (MRUS) Netherlands $0.527B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.522B 0.00
Magenta Therapeutics (MGTA) United States $0.516B 0.00
Arcus Biosciences (RCUS) United States $0.509B 0.00
Anika Therapeutics (ANIK) United States $0.505B 20.02
Stemline Therapeutics (STML) United States $0.503B 0.00
Cytokineticsorporated (CYTK) United States $0.477B 0.00
Verastem (VSTM) United States $0.476B 0.00
Zealand Pharma (ZEAL) Denmark $0.475B 0.00
Evelo Biosciences (EVLO) United States $0.462B 0.00
Sinovac Biotech (SVA) China $0.439B 0.00
Zymeworks (ZYME) Canada $0.421B 0.00
Unum Therapeutics (UMRX) United States $0.420B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.418B 0.00
MiMedx (MDXG) United States $0.415B 17.81
Achillion Pharmaceuticals (ACHN) United States $0.396B 0.00
Inovio Pharmaceuticals (INO) United States $0.393B 0.00
Albireo Pharma (ALBO) United States $0.389B 0.00
Vericel (VCEL) United States $0.389B 0.00
Syros Pharmaceuticals (SYRS) United States $0.385B 0.00
PDL BioPharma (PDLI) United States $0.383B 3.91
GTx (GTXI) United States $0.379B 0.00
Scholar Rock Holding (SRRK) United States $0.377B 0.00
Cellular Biomedicine (CBMG) United States $0.374B 0.00
Kindred Biosciences (KIN) United States $0.362B 0.00
RA PHARMCTL INC (RARX) United States $0.361B 0.00
Vital Therapies (VTL) United States $0.358B 0.00
MediciNova (MNOV) United States $0.351B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.346B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.339B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.335B 0.00
Seres Therapeutics (MCRB) United States $0.330B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.327B 0.00
Clearside Biomedical (CLSD) United States $0.319B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.315B 0.00
Adverum Biotechnologies (ADVM) United States $0.314B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.306B 0.00
Kala Pharmaceuticals (KALA) United States $0.302B 0.00
BioTime (BTX) United States $0.301B 0.00
Celyad SA (CYAD) Belgium $0.296B 0.00
Kezar Life Sciences (KZR) United States $0.296B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.287B 0.00
Athersys (ATHX) United States $0.286B 0.00
Selecta Biosciences (SELB) United States $0.285B 0.00
Synlogic (SYBX) United States $0.280B 0.00
MeiraGTx Holdings (MGTX) United States $0.274B 0.00
Kadmon Holdings (KDMN) United States $0.266B 0.00
Axovant Sciences (AXON) United Kingdom $0.265B 0.00
OVID THERAPEUTC (OVID) United States $0.264B 0.00
NantKwest (NK) United States $0.257B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.255B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.251B 0.00
Mersana Therapeutics (MRSN) United States $0.249B 0.00
ResTORbio (TORC) United States $0.245B 0.00
ChromaDex (CDXC) United States $0.240B 0.00
Celcuity (CELC) United States $0.237B 0.00
Allena Pharmaceuticals (ALNA) United States $0.236B 0.00
Strongbridge Biopharma (SBBP) United States $0.230B 0.00
Kamada (KMDA) Israel $0.230B 18.39
Cue Biopharma (CUE) United States $0.226B 0.00
Enzo Biochem (ENZ) United States $0.225B 0.00
Cohbar (CWBR) United States $0.225B 0.00
MannKind (MNKD) United States $0.223B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.221B 0.00
Agenus (AGEN) United States $0.220B 0.00
ADMA Biologics Inc (ADMA) United States $0.219B 0.00
Signal Genetics (MGEN) United States $0.208B 0.00
XOMA (XOMA) United States $0.201B 15.31
Aeglea BioTherapeutics (AGLE) United States $0.201B 0.00
Palatin Technologies (PTN) United States $0.201B 7.77
Mustang Bio (MBIO) United States $0.201B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) $0.199B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.190B 0.00
Krystal Biotech (KRYS) United States $0.189B 0.00
Idera Pharmaceuticals (IDRA) United States $0.187B 0.00
TOCAGEN INC (TOCA) United States $0.187B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.185B 0.00
VBI Vaccines (VBIV) United States $0.175B 0.00
NewLink Genetics (NLNK) United States $0.174B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.173B 0.00
Compugen (CGEN) Israel $0.173B 0.00
Menlo Therapeutics (MNLO) United States $0.171B 0.00
Protagonist Therapeutics (PTGX) United States $0.167B 0.00
BioDelivery Sciences (BDSI) United States $0.166B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.165B 0.00
BioXcel Therapeutics (BTAI) United States $0.161B 0.00
Spero Therapeutics (SPRO) United States $0.159B 0.00
Monster Digital (INNT) United States $0.159B 0.00
Intec Pharma (NTEC) Israel $0.154B 0.00
XBiotech (XBIT) United States $0.154B 0.00
Bellerophon Therapeutics (BLPH) United States $0.151B 0.00
Cerecor (CERC) United States $0.146B 23.30
Cocrystal Pharma (COCP) United States $0.146B 0.00
Pluristem Therapeutics (PSTI) Israel $0.144B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.143B 0.00
Organovo Holdings (ONVO) United States $0.142B 0.00
Anavex Life Sciences (AVXL) United States $0.141B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.141B 0.00
Fortress Biotech (FBIO) United States $0.138B 0.00
Pfenex (PFNX) United States $0.133B 0.00
PSivida (EYPT) United States $0.132B 0.00
Motif Bio Plc (MTFB) United States $0.126B 0.00
Catalyst Biosciences (CBIO) United States $0.124B 0.00
Cidara Therapeutics (CDTX) United States $0.122B 0.00
Leap Therapeutics (LPTX) United States $0.120B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.114B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.113B 0.00
Gemphire Therapeutics (GEMP) United States $0.112B 0.00
Aptevo Therapeutics (APVO) United States $0.111B 0.00
Aptose Biosciences (APTO) Canada $0.105B 0.00
Trevena (TRVN) United States $0.102B 0.00
Tapimmune (TPIV) United States $0.099B 0.00
Asterias Biotherapeutics (AST) United States $0.099B 0.00
Proteostasis Therapeutics (PTI) United States $0.099B 0.00
GENPREX INC (GNPX) United States $0.096B 0.00
Ophthotech (OPHT) United States $0.094B 0.65
Sophiris Bio (SPHS) United States $0.093B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.091B 0.00
Eleven Biotherapeutics (SESN) United States $0.090B 0.00
Alcobra (ARCT) Israel $0.089B 0.00
ScPharmaceuticals (SCPH) United States $0.089B 0.00
Checkpoint Therapeutics (CKPT) United States $0.089B 0.00
Oncolytics Biotech (ONCY) Canada $0.087B 0.00
Orgenesis (ORGS) United States $0.087B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.085B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.084B 0.00
Axsome Therapeutics (AXSM) United States $0.081B 0.00
VIVUS (VVUS) United States $0.079B 0.00
Advaxis (ADXS) United States $0.078B 0.00
Alimera Sciences (ALIM) United States $0.076B 0.00
Evogene (EVGN) Israel $0.075B 0.00
Celldex Therapeutics (CLDX) United States $0.074B 0.00
Applied Genetic Technologies (AGTC) United States $0.073B 0.00
Prima BioMed (IMMP) Australia $0.071B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.070B 0.00
OncoSec Medical (ONCS) United States $0.069B 0.00
Entera Bio (ENTX) Israel $0.068B 0.00
Histogenics (HSGX) United States $0.068B 0.00
Protalix BioTherapeutics (PLX) Israel $0.065B 0.00
Eyenovia (EYEN) United States $0.065B 0.00
Novelion Therapeutics (NVLN) Canada $0.064B 0.00
Neothetics (EVFM) United States $0.064B 0.00
Aileron Therapeutics (ALRN) United States $0.063B 0.00
Vascular Biogenics (VBLT) Israel $0.063B 0.00
VolitionRX (VNRX) Singapore $0.060B 0.00
Curis (CRIS) United States $0.057B 0.00
Zosano Pharma (ZSAN) United States $0.052B 0.00
Celsion (CLSN) United States $0.052B 0.00
Caladrius Biosciences (CLBS) United States $0.052B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.047B 0.00
VTv Therapeutics (VTVT) United States $0.047B 0.00
Moleculin Biotech (MBRX) United States $0.047B 0.00
TRACON Pharmaceuticals (TCON) United States $0.046B 0.00
BioPharmX (BPMX) United States $0.045B 0.00
AZURRX BIOPHARM (AZRX) United States $0.043B 0.00
Arsanis (ASNS) United States $0.043B 0.00
Proteon Therapeutics (PRTO) United States $0.043B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.042B 0.00
CytRx (CYTR) United States $0.041B 0.00
Cellect Biotechnology (APOP) Israel $0.040B 0.00
Chiasma (CHMA) United States $0.039B 0.00
AquaBounty Technologies (AQB) United States $0.039B 0.00
OvaScience (OVAS) United States $0.033B 0.00
VistaGen Therapeutics (VTGN) United States $0.032B 0.00
AEterna Zentaris (AEZS) United States $0.032B 0.00
Edge Therapeutics (EDGE) United States $0.031B 0.00
Benitec Biopharma (BNTC) Australia $0.030B 0.00
Oncobiologics (ONS) United States $0.029B 0.00
Vical (VICL) United States $0.028B 0.00
Cleveland BioLabs (CBLI) United States $0.027B 0.00
Synthetic Biologics (SYN) United States $0.026B 0.00
ATyr Pharma (LIFE) United States $0.026B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.025B 0.00
RestorGenex (DFFN) United States $0.023B 0.00
CorMedix Inc (CRMD) United States $0.023B 0.00
Fibrocell Science Inc (FCSC) United States $0.022B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.022B 0.00
Genetic Technologies (GENE) Australia $0.021B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Prana Biotechnology (PRAN) Australia $0.020B 0.00
Pulmatrix (PULM) United States $0.020B 0.00
AmpliPhi Biosciences (APHB) United States $0.018B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.018B 0.00
Neuralstem (CUR) United States $0.018B 0.00
Cel-Sci (CVM) United States $0.017B 0.00
Novogen (KZIA) Australia $0.016B 0.00
Flex Pharma (FLKS) United States $0.016B 0.00
Hemispherx BioPharma (HEB) United States $0.014B 0.00
Cerulean Pharma (DARE) United States $0.014B 0.00
Therapix Biosciences (TRPX) Israel $0.012B 5.93
Soligenix (SNGX) United States $0.011B 0.00
Alliqua BioMedical (ALQA) United States $0.011B 0.00
Galena Biopharma (SLS) United States $0.010B 0.00
ImmunoCellular Therapeutics (IMUC) United States $0.010B 0.00
Tenax Therapeutics (TENX) United States $0.010B 0.00
IBio (IBIO) United States $0.010B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.010B 0.00
MYOS RENS Technology (MYOS) United States $0.009B 0.00
ARCA Biopharma (ABIO) United States $0.008B 0.00
Immune Pharmaceuticals (IMNP) United States $0.007B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Oragenics (OGEN) United States $0.004B 0.00
TrovaGene (TROV) United States $0.004B 0.00
Aytu Bioscience (AYTU) United States $0.002B 0.00